Insulin-like growth factor II mediates resveratrol stimulatory effect on cathepsin D in breast cancer cells

被引:15
作者
Vyas, S
Asmerom, Y
De León, DD
机构
[1] Loma Linda Univ, Sch Med, Dept Physiol, Loma Linda, CA 92350 USA
[2] Loma Linda Univ, Sch Med, Dept Anat, Loma Linda, CA USA
关键词
resveratrol; cathepsin D; insulin-like growth factor II; breast cancer;
D O I
10.1080/08977190500366068
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cathepsin D (CD) is an enzyme that promotes breast cancer. CD is stored intracellularly; however, we demonstrated that IGF-II promotes CD secretion in estrogen receptor positive (ER+) breast cancer cells. We also showed that resveratrol (RSV) stimulates IGF-II in ER(+) breast cancer cells. Thus, we designed this study to determine whether RSV regulates CD in MCF-7, T47D (ER+) breast cancer cells as well as in Hs578t (cancer) and MCF-10A (normal) ER- cell lines. RSV (10(-6) M) increased CD and IGF-II secretion in ER+ but not ER- cells. RSV treatment (10(-4) M) inhibited CD in ER+ but not in ER- cells. Transfection of ER- cells with proIGF-II increased CD secretion. RSV (10(-6) M) modulates CD secretion through IGF-II while RSV (10(-4) M) inhibits CD in ER+ but not ER- cells. Regulation of CD by RSV represents a novel mechanism by which RSV may protect against breast cancer.
引用
收藏
页码:79 / 87
页数:9
相关论文
共 32 条
  • [1] Aziz MH, 2003, INT J ONCOL, V23, P17
  • [2] Cathepsin-D affects multiple tumor progression steps in vivo:: proliferation, angiogenesis and apoptosis
    Berchem, G
    Glondu, M
    Gleizes, M
    Brouillet, JP
    Vignon, F
    Garcia, M
    Liaudet-Coopman, E
    [J]. ONCOGENE, 2002, 21 (38) : 5951 - 5955
  • [3] Cancer chemopreventive activity of resveratrol
    Bhat, KPL
    Pezzuto, JM
    [J]. ALCOHOL AND WINE IN HEALTH AND DISEASE, 2002, 957 : 210 - 229
  • [4] CATHEPSIN-D GENE IS CONTROLLED BY A MIXED PROMOTER, AND ESTROGENS STIMULATE ONLY TATA-DEPENDENT TRANSCRIPTION IN BREAST-CANCER CELLS
    CAVAILLES, V
    AUGEREAU, P
    ROCHEFORT, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) : 203 - 207
  • [5] Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D
    Claussen, M
    Kubler, B
    Wendland, M
    Neifer, K
    Schmidt, B
    Zapf, J
    Braulke, T
    [J]. ENDOCRINOLOGY, 1997, 138 (09) : 3797 - 3803
  • [6] CONOVER CA, 1994, J BIOL CHEM, V269, P7076
  • [7] THE 3RD IGF-II PROMOTER SPECIFIES TRANSCRIPTION OF 3 TRANSCRIPTS OUT OF 5 IN HUMAN PLACENTA
    DAIMON, M
    JOHNSON, TR
    ILAN, J
    ILAN, J
    [J]. MOLECULAR REPRODUCTION AND DEVELOPMENT, 1992, 33 (04) : 413 - 417
  • [8] Damianaki A, 2000, J CELL BIOCHEM, V78, P429, DOI 10.1002/1097-4644(20000901)78:3<429::AID-JCB8>3.0.CO
  • [9] 2-M
  • [10] Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II)
    De León, DD
    Issa, N
    Nainani, S
    Asmerom, Y
    [J]. HORMONE AND METABOLIC RESEARCH, 1999, 31 (2-3) : 142 - 147